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INVESTIGATING THE ROLE OF STRIATAL SPINY PROJECTION NEURONS IN 
COMPULSIVE BEHAVIORS 
 
Brittany Lynn Chamberlain, BS, BA 
 





Obsessive compulsive disorder (OCD) is a chronic, severe mental illness that affects 2-3% of the 
world’s population. In recent years, neuroimaging studies have consistently shown abnormal 
patterns of activity within corticostriatal thalamocortical (CSTC) circuits in patients with OCD 
and reported that effective treatment with selective serotonin reuptake inhibitors (SSRIs) 
normalizes aberrant CSTC activity. However, the mechanism of this effect is unknown. 
Because it is difficult, if not impossible, to investigate cellular and circuit mechanisms in 
human subjects, our lab turns to translational mouse models. Using Sapap3-knockout (KO) mice, 
which display a compulsive grooming phenotype and corticostriatal abnormalities, we sought to 
determine the role of spiny projection neurons (SPNs) in mediating compulsive behavior and to 
uncover potential neural correlates of effective SSRI administration. Using novel in vivo calcium 
imaging technology, we observed overall striatal hyperactivity in Sapap3-KO mice at grooming-
onset relative to wild-type (WT) littermates, an effect that is driven by increased recruitment of 
groom onset-activated SPNs. SSRI treatment reduced the compulsive grooming behavior of 
Sapap3-KOs and decreased the neural correlate of this behavior, the percent of groom onset-
activated SPNs observed in Sapap3-KOs. 
To investigate the contributions of individual striatal subpopulations to the overall striatal 
hyperactivity observed in Sapap3-KOs, we used a double-transgenic strategy to generate D1-cre 
x Sapap3-KO and D1-cre x Sapap3-WT mice. Contrary to our predictions, we observed a 
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significant reduction in activity of D1-SPNs in Sapap3-KOs relative to WT mice. Following 7 
days SSRI treatment, the compulsive grooming phenotype of D1-cre x Sapap3-KO mice was 
significantly reduced, but only minor changes in D1-SPN activity were observed. These findings 
suggest that D2-SPNs may be responsible for driving grooming-associated striatal hyperactivity 
in Sapap3-KO mice. While additional research is necessary to attain a more comprehensive 
understanding of the corticostriatal abnormalities in this translational model, the present findings 
provide clinically-relevant insights into the circuit level mechanisms underlying compulsive 
behaviors and the mechanisms by which SSRI treatment effectively reduces them. 
 vi 
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1.1 Obsessive compulsive disorder 
Obsessive compulsive disorder (OCD) is a chronic, severe mental illness that affects 2-3% of the 
world’s population. OCD is characterized by two main symptom categories: intrusive distressing 
thoughts (obsessions) and repetitive behavioral acts (compulsions). This chronic disorder often 
begins in adolescence or early adulthood and can have an incredible impact on daily functioning 
and quality of life. Despite its severity and high prevalence, there is limited understanding of the 
precise mechanisms underlying OCD, and current treatment methods have limited efficacy. 
1.1.1  Structural abnormalities in OCD 
MRI studies that use voxel-based morphometry (VBM) to examine region-specific changes in gray 
matter volume have repeatedly reported significant volumetric alterations when comparing scans 
from OCD patients and healthy control subjects. In particular, studies report an increase in gray 
matter volume of the basal ganglia (Piras et al. 2015; Pujol et al. 2004; Rotge et al. 2009) and 
thalamus (Piras et al. 2015; Kim 2001; Christian et al. 2008; Rotge et al. 2009) in OCD patients 
relative to healthy controls. Additionally, several VBM studies have reported observing decreased 
gray matter volume in the anterior cingulate cortex (ACC) and orbitofrontal cortex (OFC) of OCD 
patients (Piras et al. 2015; Kim 2001; Van Den Heuvel et al. 2008). It is important to note that the 
results of structural MRI studies have been fairly heterogenous, with some studies reporting 
significant increases in cortical volume or decreases in striatal and thalamic volume. These 
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inconsistencies highlight our lack of understanding of the precise mechanisms that underlie 
structural changes in patients with OCD. To investigate these mechanisms further, it is necessary 
to examine how functional connectivity in corticostriatal thalamocortical (CSTC) circuits may be 
altered in OCD. 
1.1.2  Functional abnormalities in OCD 
Over the past two decades, mounting evidence has indicated that aberrant activity in CSTC 
circuitry may underlie OCD symptoms. fMRI and PET studies have repeatedly reported abnormal 
patterns of blood flow and glucose metabolism in CSTC regions in OCD patients. Specifically, at 
rest, glucose metabolism is increased in the OFC, ACC, and caudate nucleus of OCD patients 
compared to healthy control subjects (Graybiel and Rauch 2000; Saxena 1998; Menzies et al. 
2008). Several studies have shown that this hypermetabolism is further accentuated upon symptom 
provocation by comparing glucose metabolism within subjects before and after showing a stimulus 
that has reportedly provoked OCD symptoms on previous occasions (Saxena 1998).  
Effective treatment response appears to normalize metabolic rates in corticostriatal regions: 
in a group of OCD patients who received either serotonin reuptake inhibitors or cognitive 
behavioral therapy, glucose metabolism was significantly reduced in treatment-responsive 
individuals but not in nonresponders (Saxena 1999; Rauch 1994). fMRI studies have reported 
similar abnormal patterns of CSTC activation during symptom exposure that is normalized 
following effective treatment (Menzies et al. 2008; Breiter 1996). The correlation between 
normalization of corticostriatal activity and symptom reduction provides further evidence for the 
role of CSTC circuits in OCD pathophysiology. 
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Furthermore, fMRI studies can assess patterns of functional connectivity by performing 
seed-based cross-correlation analyses of subjects’ resting-state imaging sequences. These studies 
have reported that patterns of functional connectivity between cortical and striatal regions are 
significantly altered in OCD patients compared to healthy control subjects. Specifically, one study 
reported that OCD patients had increased functional connectivity between ventral striatal regions 
(ventral caudate and putamen) and medial orbitofrontal cortex (mOFC) and that the strength of 
functional connectivity between ventral corticostriatal regions was predictive of symptom severity 
(Harrison et al. 2009). This finding was consistent with PET studies that report hypermetabolism 
in corticostriatal regions at baseline that is normalized with effective treatment and provides further 
support for the belief that CSTC circuit dysfunction underlies OCD pathophysiology (Burguiere 
et al. 2013). 
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1.1.3  Corticostriatal thalamocortical circuitry in OCD 
It is well-established that the coordinated activity of the cortex, basal ganglia, and thalamus that 
comprise the CSTC circuit is pertinent for the execution of several cognitive and motor functions, 
including decision-making, action 
selection, and habit formation (Shepherd 
2013; Pennartz et al. 2009). Given the 
symptomology of OCD (mental 
obsessions and behavioral compulsions), 
it is unsurprising that a wealth of 
structural and functional neuroimaging 
literature has implicated CSTC circuit 
dysfunction in the pathophysiology of 
the illness. The cortical regions of the 
CSTC circuit include the OFC, 
prefrontal cortex (PFC), and ACC, all of 
which have been implicated in 
motivation and determining reward preferences (Graybiel and Rauch 2000). The striatum 
integrates information from the cortex, thalamus, and midbrain regions to guide the selection of 
adaptive actions, projecting through basal ganglionic regions to the thalamus. In the final piece of 
the CSTC loop, the thalamus projects back to cortex, activating motor cortex such that the selected 
action is executed. Under normal conditions, then, CSTC circuitry guides progression from a 
cognitive framework, established in the cortex, to a corresponding behavioral output that is adapted 











Coordinated activity in the OFC, striatum, and thalamus give rise 
to decision-making, action selection, and habit formation. 
Neuroimaging studies implicate aberrant activity in these regions 







Schematic 1.1 Corticostriatal thalamocortical circuitry 
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in patients becoming stuck in one cognitive framework, rendering them unable to transition to 
other behavioral outputs when a given behavior is no longer adaptive for their environment 
(Graybiel and Rauch 2000). This theory is commonly illustrated by considering an OCD patient 
with a contamination obsession. In this case, an anxiety-provoking stimulus may be seeing a cut 
on another person’s hand, leading to subsequent feelings of distress over fear of a disease being 
carried through the air from the cut and infecting the patient. To seek relief from this distressing 
thought, the patient may perform a ritualistic behavior; in this case, excessive hand washing. 
Feeling momentary relief from their distressing thoughts, their compulsive behavior becomes 
reinforced, making it more probable that the patient will repeat this compulsive behavior the next 
time they encounter an anxiety-provoking stimulus (Pauls et al. 2014). This example is particularly 
insightful because it highlights that the ritualistic behaviors that OCD patients engage in are not 
inherently negative. Rather, the associated anxiety-relief that a certain behavior yields results in 
reinforcement of that behavior in a manner that becomes compulsive in nature over time. 
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1.1.3.1 Role of central striatum in adaptive action selection  
The key locus of the CSTC circuit that is investigated in this study is the central striatum. The 
striatum receives input from sensory, motor, and associative cortices, and integrates these inputs 
to select adaptive motor programs for initiating 
goal-directed behaviors. The central striatum is 
composed of 95% GABAergic spiny projection 
neurons (SPNs) (Gagnon et al. 2017). SPNs can 
be further subdivided into two genetically-distinct 
subpopulations: dopamine 1 receptor- (D1-) and 
dopamine 2 receptor-expressing (D2-) cells. 
D1-SPNs contain the amino acid 
substance P and the opioid peptide dynorphin and 
selectively project to the internal globus pallidus 
(GPi) and substantia nigra pars reticulata (SNr) 
(Surmeier et al. 2007). The GPi and SNr send 
inhibitory projections to the thalamus. Inhibition 
of the GPi and SNr by D1-SPNs in striatum 
disinhibits the thalamus, which then sends 
excitatory projections to the cortex, directing the 
execution of voluntary, goal-directed movements. 
In contrast, D2-SPNs contain enkephalin and 
selectively project to the external globus pallidus 



























The output structures of D1- and D2-SPNs diverge to 
make the direct and indirect pathways of basal ganglia. 
Through the direct pathway, D1-SPNs send inhibitory 
projections to GPi and SNr, disinhibiting the thalamus. 
Thalamus sends excitatory projections to cortex, 
directing initiation of desired movements. D2-SPNs 
send inhibitory projections to GPe, disinhibiting the 
GPi and SNr. When disinhibited, GPi and SNr send 
inhibitory projections to thalamus, decreasing 
thalamic drive to cortex and thereby inhibiting 
initiation of unwanted movements.  
Schematic 1.2 Direct and indirect pathways 
of basal ganglia 
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projecting to the thalamus directly, GPe neurons send GABAergic projections to the subthalamic 
nucleus (STN). Inhibition of the GPe by D2-SPNs in striatum results in disinhibition of the STN. 
When disinhibited, the STN sends excitatory projections to the GPi and SNr, reinforcing the 
inhibition of the thalamus and inhibiting thalamic drive of the cortex.  
Dopaminergic input onto D1- and D2-SPNs originates in the substantia nigra pars 
compacta (SNc). Rather than acting to directly excite or inhibit striatal SPNs, dopaminergic 
signaling from the SNc modulates the effect of excitatory neurotransmission entering the striatum 
from cortex (Surmeier et al. 2007). Dopamine 1 and dopamine 2 receptors are G-protein coupled 
receptors (GPCRs), and agonist binding to each of these receptors results in a distinct intracellular 
signaling cascade. Dopamine 1 receptors are coupled to adenylyl cyclase via the alpha subunit of 
a GTP-binding protein, Golf (Gagnon et al. 2017). Dopaminergic binding to a dopamine 1 receptor 
stimulates an increase in the production of the secondary messenger, cyclic adenosine 
monophosphate (cAMP), and increased cytosolic levels of cAMP activates protein kinase A 
(PKA), an enzyme that phosphorylates several downstream targets (Gagnon et al. 2017). One of 
the molecules phosphorylated by PKA is a dopamine- and cAMP-regulated phosphoprotein 
(DARPP-32). Phosphorylation of DARPP-32 converts it into a protein phosphatase-1 inhibitor, 
and activation of this intracellular pathway ultimately results in increased opening of L-type 
calcium channels, increasing the excitability of the spiny projection neuron in response to 
glutamatergic signaling (Beaulieu and Gainetdinov 2011). 
In contrast, activation of dopamine 2 receptors negatively modulates cAMP production. 
Dopaminergic binding to a dopamine 2 receptor reduces cAMP levels, consequently decreasing 
the activation of PKA, prohibiting PKA from activating downstream targets, including DARPP-
32 (Beaulieu and Gainetdinov 2011). Activation of dopamine 2 receptors inhibits L-type calcium 
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channels and activates G-protein coupled inwardly rectifying potassium channels, attenuating SPN 
excitability to glutamatergic synaptic transmission (Gagnon et al. 2017; Svenningsson et al. 2004; 
Beaulieu and Gainetdinov 2011).  
Due to their contrasting functions in modulating striatal excitability and their distinct 
anatomical outputs, D1- and D2-SPNs are canonically described as playing antagonistic roles in 
regulating intentional movements via the direct and indirect pathways, respectively, whereby the 
D1-SPN “direct pathway” facilitates initiation of voluntary, desirable movements and the D2-SPN 
“indirect pathway” inhibits initiation of involuntary, unwanted movements. Given this framework 
and the symptomology of OCD, it has been suggested that OCD arises from an imbalance in the 
activation of direct and indirect pathways (Maia, Cooney, and Peterson 2008). Specifically, 
abnormal excitation of the direct pathway over the indirect pathway could conceivably give rise 
to the compulsive behaviors and obsessive thoughts associated with OCD.  
1.1.4  Genetic basis of OCD 
While the etiology of corticostriatal abnormalities in OCD are unknown, twin studies indicate a 
possible genetic contribution. A recent meta-analysis of twin studies reported that additive genetic 
effects accounted for 40% of phenotypic variance, while shared environment did not have a 
significant contribution (Taylor 2011).  Additionally, genome-wide association studies (GWAS) 
indicate that genes that encode for proteins found at and around excitatory synapses may account 
for this genetic contribution (Kalueff et al. 2015). Specifically, disease-associated GWAS single 
nucleotide polymorphisms (SNPs) included DLGAP1, a gene that encodes a post-synaptic density 
scaffolding protein, and ISM1, a gene that is highly correlated with brain-wide expression of 
multiple glutamate-related genes, including members of the DLGAP protein family and GRIK1 
 9 
and GRIK4, genes that encode for glutamate receptor subunits (Stewart et al. 2013). A second 
GWAS reported a significant association near the PTPRD gene, which encodes the receptor 
protein tyrosine phosphatase. PTPRD promotes the differentiation of glutamatergic synapses and 
interacts with SLITRK proteins which are critical for proper formation of excitatory synapses 
(Mattheisen et al. 2015). The relevance of this association to OCD behaviors has been investigated 
by knocking out Slitrk5 in mice. Slitrk5-KO mice display OCD-relevant behaviors, including a 
self-injurious overgrooming phenotype (Shmelkov et al. 2010). Furthermore, corticostriatal 
neurotransmission of Slitrk-KOs was examined by staining for FosB in orbitofrontal cortex. FosB 
expression was significantly higher in Slitrk-KO mice relative to wild-type littermates, indicating 
that Slitrk-KO mice had higher OFC activity which is consistent with functional neuroimaging 
literature in OCD patients (Shmelkov et al. 2010). 
1.1.5  Sapap3-knockout mice  
While it is difficult, if not impossible, to investigate cellular and circuit mechanisms in human 
subjects, this can be done by utilizing animal models of compulsive behavior that display altered 
CSTC activity. One such model is Sapap3-KO mice. SAPAP family proteins are scaffolding 
proteins found in the postsynaptic density that act to regulate trafficking of AMPA-and NMDA-
type glutamate receptors to the postsynaptic membrane of excitatory synapses (Welch et al. 2007). 
SAPAP3 is the only member of the SAPAP family proteins that is specifically enriched in the 
striatum, and mice with global deletion of the Sapap3 gene display a compulsive grooming 
phenotype, often grooming to the self-injurious extent of developing skin lesions around the neck 
and face (Welch et al. 2007). When striatal SAPAP3 expression is rescued via lentiviral injection 
of SAPAP3 into the striatum specifically, the grooming phenotype of Sapap3-KO mice is reduced 
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to WT levels, providing construct validity for this animal model of striatal-dependent compulsive 
behavior (Welch et al. 2007). In addition to this compulsive grooming phenotype, Sapap3-KO 
mice display other OCD-relevant phenotypes including increased levels of anxiety and impaired 
cognitive flexibility, providing additional evidence of the relevance of this animal model for 
investigating the mechanisms of OCD pathophysiology (Welch et al. 2007; Manning et al. 2018). 
Furthermore, corticostriatal transmission is also altered in Sapap3-KO mice (Welch et al. 
2007; Burguiere et al. 2013). Slice physiology recordings from striatal slices of Sapap3-KO mice 
and WT littermates show that field excitatory postsynaptic potentials (fEPSPs) are significantly 
reduced in Sapap3-KOs relative to WT animals, while axonal excitability and presynaptic 
functions are unchanged, indicating that the change in fEPSPs is the result of postsynaptic 
impairments (Welch et al. 2007). Moreover, in vivo electrophysiological recordings of resting local 
field potentials in Sapap3-KOs and WTs show significant elevation in baseline firing rates of 
striatal spiny projection neurons in KOs relative to WTs (Burguiere et al. 2013). Optogenetic 
stimulation of lateral orbitofrontal cortex (lOFC) terminals in the central striatum results in a 
reduction of striatal SPN firing rates and a subsequent significant reduction of grooming levels in 
Sapap3-knockout animals (Burguiere et al. 2013). These novel findings suggest that the 
compulsive grooming behavior of Sapap3-knockout mice is causally related to alterations in CSTC 
circuitry, making them a relevant model to investigate how CSTC abnormalities give rise to 
compulsive behaviors. 
Another important characteristic of Sapap3-knockout mice that makes them an ideal model 
for the present study is their treatment responsiveness. When treated with a common selective 
serotonin reuptake inhibitor (SSRI), fluoxetine, over the course of 6 days, grooming behavior is 
significantly reduced in KO mice, without affecting the grooming levels of WT littermates (Welch 
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et al. 2007). The underlying mechanism of this effect is currently unknown, but through exploring 
the effects of SSRI treatment on Sapap3-KO and WT cellular activity in vivo, researchers can 
glean insight into the mechanisms by which SSRI treatment is effective – or fails to be effective – 
in patients with OCD. 
Most recently, the first post-mortem study of differential gene expression in OFC and 
striatum of subjects with OCD and matched comparison subjects implicated the relevance of 
SAPAP3 expression in OCD. Expression of the DLGAP3 gene (synonymous with Sapap3 in 
mouse genome) was significantly decreased in medial OFC, lateral OFC, nucleus accumbens core, 
and head of caudate in OCD subjects relative to matched comparison subjects. This finding 
provides further support for the hypothesis that decreases in SAPAP3 protein are involved in the 
generation of compulsive behaviors. 
1.1.6  Selective serotonin reuptake inhibitors 
SSRIs are the first-line monopharmacotherapy for OCD. While other psychotropic medications, 
including mood stabilizers, tricyclic antidepressants, benzodiazepines, and monoamine oxidase 
inhibitors all fail to have any effect on the core symptoms of OCD, SSRI treatment yields symptom 
improvement in 40-60% of patients (Goddard et al. 2008). However, nearly half of patients report 
feeling no significant change in their symptoms with SSRI treatment, and full remission is 
achieved with this pharmacologic treatment in only 25% of the patient population (Goddard et al. 
2008). 
SSRIs act by blocking the serotonin transporter (5-HTT) to increase intrasynaptic 
concentrations of serotonin. Importantly, in addition to increasing levels of serotonin in the frontal 
cortex, striatum, and hippocampus, acute SSRI administration also serves to decrease the 
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functional connectivity between cortical and subcortical regions(van de Ven et al. 2013; McCabe 
et al. 2011). Given that cortical-subcortical connectivity is significantly increased in untreated 
OCD patients relative to healthy controls (Harrison et al. 2009), SSRI treatment may serve to 
attenuate symptoms by normalizing activity throughout the corticostriatal circuit. 
The mixed effectiveness of SSRIs for managing OCD symptoms is reflective of the fact 
that this pharmacologic treatment is unspecific, and the mechanism by which SSRIs decrease 
obsessional and compulsive symptoms is largely unknown. Chronic SSRI administration alters 
serotonergic neurotransmission, often depleting concentrations of tryptophan (a precursor to 
serotonin) and serotonin (Goddard et al. 2008). In major depressive disorder, symptom 
management with SSRIs depends on maintaining the availability of presynaptic serotonin, but in 
OCD, the therapeutic effect of SSRI administration appears to be unaltered by serotonin depletion, 
indicating that the mechanism of action by which SSRIs attenuate OCD symptoms is long-term 
and based in changes at the post-synaptic density (Goddard et al. 2008; Berney 2005; Barr LC 
1994). While it is encouraging that SSRIs provide symptomatic relief to a subset of OCD patients, 
it is important to investigate the underlying mechanism by which SSRIs grant symptomatic relief, 
such that this mechanism can be exploited and improved upon to yield greater therapeutic efficacy 
as a pharmacotherapy for OCD. 
1.1.7  In vivo calcium imaging 
In vivo calcium imaging enables researchers to record cellular activity from hundreds of neurons 
per mouse while maintaining spatial information, a large advance from traditional 
electrophysiological techniques (Resendez et al. 2016). After acquiring spatial information from 
each neuron that is active in each recording session, researchers are able to track the activity of 
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individual neurons over the course of multiple sessions and to assess how changes in the 
experiment such as the administration of a specific drug affects the activity of individual cells, 
giving rise to the global, nonspecific changes that traditional electrophysiological techniques 
detect. Furthermore, this method allows researchers to record activity from genetically-distinct cell 
populations, as opposed to recording from all neurons within a given region (Resendez et al. 2016). 
When relying on model systems of psychiatric disease states, it is of significant importance 
that the experimental methods do not inhibit animals from performing normal behaviors. In this 
particular model system, the behavior of interest is compulsive grooming, so it is necessary that 
mice are able to carry out this behavior without being constrained due to the experimental method 
being utilized. While in vivo electrophysiology rigs confer an excess of weight that makes it 
difficult for mice to perform this behavior and in vivo two-photon fiber photometry requires 
animals to remain in a head-fixed position, in vivo calcium imaging enables mice to move about 
the behavioral chamber freely with head-mounted microscopes that are sufficiently light-weight 
not to significantly alter behavior (Resendez et al. 2016). 
More specifically, in vivo calcium imaging is achieved by injecting an adeno-associated 
virus (AAV) expressing GCaMP6m, a genetically encoded calcium indicator. GCaMP6m is 
comprised of green fluorescent protein (GFP), the calcium-binding protein calmodulin, and 
calmodulin-interacting peptide 13 (Chen et al. 2013). When the intracellular calcium concentration 
of a neuron is significantly increased (when a neuron fires an action potential), GCaMP6m 
undergoes a conformational change that results in the GFP chromophore fluorescing (Chen et al. 
2013). Therefore, observing bursts of calcium fluorescence can be used as a reliable and 
representative proxy for neural activation that can be observed in vivo at single-cell resolution. 
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1.2 Specific aims of current work 
This thesis investigates the neural activity patterns of compulsive behavior in a mouse model of 
OCD-relevant behavior. Using novel in vivo calcium imaging technology, I will assess calcium 
activity in the central striatum of Sapap3-KO mice and WT littermates to determine if there are 
genotype differences in grooming-associated calcium activity. Additionally, I will investigate the 
effects of SSRI treatment on compulsive grooming behavior and calcium activity in the central 
striatum. In Experiment 1, I examine the combined activity of D1- and D2-SPNs by utilizing a 
synapsin promoter GCaMP6m lentivirus. In Experiment 2, I begin to investigate the roles of 
individual SPN subpopulations in the manifestation of compulsive behaviors. Here, I examined 
the grooming-associated activity of D1-SPNs by injecting a Cre-dependent GCaMP6m virus into 
central striatum of D1-cre x Sapap3-KO and D1-cre x Sapap3-WT mice.  Thus, this work will 
contribute to the present understanding of the role of central striatum in compulsive behaviors and 




2.1 Experiment 1 (Synapsin Cohort)  
2.1.1  Subjects 
All procedures were conducted in accordance with the National Institute of Health’s Guide to the 
Care and Use of Laboratory Animals and approved by the University of Pittsburgh’s Institutional 
Animal Care and Use Committee. Sapap3-knockout (Sapap3-KO) and wildtype (WT) littermates 
on 100% C57BL/6 background were bred using Sapap3 heterozygous mutants (Sapap3+/-).  For 
Experiment 1, five adult male Sapap3-KO mice and five adult male WT mice were utilized, and 
behavioral and neuronal data were collected from all animals. Each animal was housed on a 12-
hour light cycle (lights on at 7AM), and all mice were approximately 4-6 months old at the time 
of the first surgical procedure.  
2.1.2  Stereotactic surgery  
In the first surgical procedure, mice were anesthetized using 5% isoflurane mixed with oxygen and 
maintained on 1-2% isoflurane throughout the duration of the surgery. Mice were placed on a 
small-animal stereotactic instrument (Kopf Instruments) and secured using a bite bar and ear bars. 
Hair was removed from the dorsal surface of the head with hair clippers, and the surface of the 
head was scrubbed with a betadine solution. After sterilizing the dorsal surface of the head, a large 
incision was made such that the dorsal portion of the skull was exposed. Skull surface was cleared 
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of remaining musculature and tissue, and bregma was located. All surgical measurements were 
made relative to the interpolated bregma. First, two .45mm skull screws were placed anterior to 
the lambdoid suture for stability. Then, a large skull window was made in the surrounding area of 
viral and implant targeting (AP: +.65mm, ML: -1.8mm), and the surgical cannula was zeroed to 
dura. Dura was removed prior to lowering surgical cannula into the brain.  
Viral injections were performed using a fixed needle Hamilton syringe (Cole-Parmer 
Scientific, Vernon Hills IL, USA) connected to sterile polyethylene tubing affixed to a metal 
cannula and a Harvard Apparatus Pump 11 Elite Syringe Pump (Harvard Apparatus, Holliston 
MA, USA).  800 nl of a virus encoding GCaMP6m under the synapsin promotor (AAV9-synapsin-
GCaMP6m-WPRE-SV40, 2.3e13) were injected into the central striatum (AP: +0.65mm, ML: -
1.8mm, DV: -2.9mm & -3.0mm). Injections were performed in a series of two steps, with 400nl 
of virus injected at DV = -2.9mm and 400nl of virus injected at DV = -3.0mm. Immediately 
following viral injection, a 500-µm-diameter graded-index lens (ProView GRIN lens, Inscopix 
Pala Alto, CA USA) was lowered just dorsal to the viral injection target  (AP: +0.65mm, ML: -
1.8mm, DV: -2.85mm) to allow for visualization of cells in the target region.  
Following lens lowering, acrylic dental cement (Lang Dental, Wheeling IL, USA) was 
utilized to create a temporary head cap that secured lens placement and sealed off the GRIN lens 
during the incubation period (4-6 weeks). Following completion of surgery, mice were injected 
with sub cutaneous (s.c.) carprofen, and topical antibiotic ointment (TAO) and lidocaine were 
administered around the temporary head cap. Mice were then placed on a heating pad, given 
DietGel, and monitored until they fully recovered from anesthesia. Mice were administered 
carprofen s.c. and received lidocaine and TAO treatments for 3 days post-surgery. For all surgical 
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procedures, mice were group-housed with littermates unless conspecific fighting was noted. In 
such cases, the aggressive mouse was isolated for the duration of the experiment. 
 
After waiting 4-6 weeks to allow for sufficient viral incubation, animals were anesthetized 
with 5% isoflurane and secured to a stereotactic apparatus using ear cuffs and a bite bar. Mice 
were maintained on 1-1.5% isoflurane for the duration of the second surgical procedure. First, the 
temporary head cap fashioned from acrylic dental cement was carefully removed using a Dremel 
tool until the ProView GRIN lens was exposed. The top of the ProView lens was then cleaned 
with compressed air and lens paper to remove all dental cement dust. A magnetic microscope 
baseplate (Part ID:1050-002192, Inscopix) was then attached to the miniaturized microscope 
(nVistaHD 2.0 epifluorescence microscope, Inscopix) and lowered into place above the GRIN lens 
with the 475nm blue LED gain and power of the miniaturized microscope set to their maximum 
levels.  Because cellular activity is minimal in deep structures such as the striatum when animals 
are anesthetized, vasculature was used as a main landmark that enabled proper focusing and 
alignment of the miniaturized microscope. Once an optimal field of view was obtained, the 
baseplate was secured in place using dental cement, and a plastic Microscope Baseplate Cover 
(Part ID:1050-002193; Inscopix) was attached to prevent debris from blocking the lens.  
2.1.3  Drug preparation and administration  
(±)Fluoxetine hydrochloride (Fluoxetine) was obtained through the NIMH Chemical Synthesis 
and Drug Supply Program. Fluoxetine was administered intraperitoneally (i.p.) according to 
previous studies which report a reduction in Sapap3-KO grooming following treatment (Welch et 
al. 2007). Sapap3-KO and WT mice received 5mg/kg fluoxetine in a .9% saline solution 
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(10mL/kg) injected i.p. daily for 7 consecutive days, consistent with the protocols outlined by 
(Welch et al. 2007).  
2.1.4  Grooming behavior and in vivo calcium imaging 
Each mouse was given a minimum of 7 days to recover from surgery before being habituated to 
the experimental chamber and miniaturized microscopes. In order to attach the microscope 
securely to the baseplate, mice were lightly scruffed while the miniature nVistaHD 2.0 microscope 
was connected to the magnetic baseplate and secured with a set screw. Mice were then placed in a 
clear acrylic chamber (8” W x 8” D x 12” H) for 5-10 minutes once daily on three consecutive 
days. During behavioral habituation, the gain and power of the miniaturized microscope LED were 
adjusted to optimize visualization of calcium fluorescence. Microscope focus was also adjusted 
and recorded using a caliper tool to assist in consistent placement of the microscope throughout 
consecutive days of the experiment. 
Following three days of habituation, baseline grooming behavior was assessed. To 
accurately capture behavioral activity, a behavioral acquisition camera (Point Grey Blackfly, FLIR 
Integrated Imaging Solutions) was placed below the behavioral chamber, recording from a bottom-
up perspective. Behavioral acquisition was conducted at 40 Hz using SpinView (Point Grey) 
software, and detailed frame information was sent directly to a central data acquisition box 
(LabJack U3-LV, Labjack Corporation, Lakewood CO USA). A randomly flashing (30s ITI) LED 
was visible in the field of view of the behavioral acquisition camera throughout the entire testing 
session. This LED was controlled by custom scripts via an Arduino (Arduino Leonardo, 
Somerville MA, USA) and sent TTL pulses to the LabJack, enabling accurate alignment of 
behavior and calcium data.  
 19 
On the baseline day of Experiment 1, grooming behavior was recorded for forty-minutes, 
and in vivo calcium activity in the striatum was simultaneously recorded throughout the entire 
session. After the microscope was attached, mice were left in a cage without cage mates for 3-5 
minutes, allowing time for animals to recover from scruffing and for any rapid photobleaching of 
calcium signal to occur. Mice were then carefully placed in the clear acrylic chamber. LabJack 
data acquisition was started, immediately followed by behavioral SpinView recordings from 
behavioral acquisition camera and nVistaHD software recording of compressed greyscale tiff 
images at 20Hz. Individual calcium frame information was sent to the LabJack as it simultaneously 
received behavioral frame acquisition, enabling subsequent alignment of behavior and calcium 
data. For all mice, analog gain of the image sensor was set between 1 and 4 while the 470 nm LED 
power was set between 10 to 30% transmission range. These settings were kept consistent for each 
mouse throughout all subsequent imaging sessions.  
Following the baseline day of Experiment 1, animals received one week of fluoxetine 
treatment. 5mg/kg fluoxetine hydrochloride in a .9% saline solution (10mL/kg) was injected i.p. 
daily for 7 days. On the eighth day, grooming behavior and calcium activity were reassessed in 
another forty-minute session following the same protocol used on the baseline day. After 
fluoxetine treatment had been completed for two weeks, a final assessment of grooming behavior 
and calcium activity was recorded for a forty-minute session. Again, this session adhered to the 
same protocol used on the baseline day and treatment day 7. 
2.1.5  Behavioral analysis 
Following acquisition of behavioral data, video files were converted and compressed (maintaining 
accurate frame rate information) into .MP4 format using the open source software HandBrake. 
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Videos were imported into Noldus The Observer XT (Noldus Leesburg VA, USA). Animal 
grooming behavior was scored frame-by-frame by observers that were blind to experimental 
conditions. Three grooming behaviors were assessed: facial grooming, body grooming, and hind-
leg scratching (Figure 2.1) The start of a facial grooming bout was defined by the frame in which 
the animal started to move its front limbs from the ground toward the face. The start of a body 
grooming bout was defined by the frame in which the animal shifted its weight and began to turn 
its head toward its flank. The start of a hind-leg scratching bout was defined by the frame in which 
the animal positioned its weight and started to lift a hind-leg toward its flank or face. The cessation 
of all grooming bouts was defined by the frame in which the animal had fully completed the 
grooming behavior and returned to a neutral body position.  
 
Figure 2.1 Pictorial Example of Grooming Behaviors  
This figure shows representative examples of grooming behaviors. (A), (B), and (C) represent facial grooming in 
which the mice grooms around its snout, face, and ears. (D) represents body grooming in which the animal turns to 
one side to lick their flank. This figure was adapted from (Berridge et al. 2005). 
2.1.6  Calcium imaging data processing 
All imaging pre-processing was performed using Mosaic software (Mosaic 1.2.0, Inscopix) via 
custom Matlab (MATHWORKS, Natick MA, USA) scripts. Videos were spatially downsampled 
by a binning factor of 4 (16x spatial downsample) and temporally downsampled by a binning 
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factor of 2 (down to 10 frames per second). Lateral brain motion was corrected using the 
registration engine TurboReg (Ghosh et al. 2011) which uses a single reference frame to match the 
XY positions of each frame throughout the video. Motion-corrected 10 Hz video of raw calcium 
activity was then saved as a .TIFF and used for cell identification. 
Using custom Matlab scripts, the motion-corrected .TIFF video was processed using the 
Constrained Non-negative Matrix Factorization approach (CNMFe), which has been optimized to 
isolate signals from individual putative neurons from microendoscopic imaging (Zhou et al. 2018). 
The CNMFe method is able to simultaneously denoise, deconvolve, and demix imaging 
data (Pnevmatikakis et al. 2016) and represents an improvement over previously used algorithms 
based on principle component analysis (Zhou et al. 2018). The primary improvement comes from 
accurate estimation and subtraction of both local and global background fluorescence signal, 
providing better separation of densely packed cells and a cleaner overall calcium signal from 
individual putative cells. 
After processing in CNMFe, putative neurons were identified and manually sorted by an 
observer blind to genotype according to previously established criteria (Resendez et al. 2016). For 
the data presented in this thesis, I report the non-denoised temporal traces (referred to as the “raw” 
trace in CNMFe) without any deconvolution. For each individual cell, the raw fluorescence trace 
was Z-scored to the average fluorescence of that same trace. Thus, fluorescence units presented 
are referred to as “Z-scored fluorescence”.   
2.1.7  Calcium imaging analysis 
Custom Matlab (MATHWORKS) scripts were used to analyze of grooming-associated calcium 
activity. Grooming behaviors (state events) were exported as timestamps (grooming start and 
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grooming stop) and aligned to calcium time based on the first 5 consecutive LED pulses recorded 
from the behavioral acquisition camera (point events). The offset of Noldus behavior time to 
nVista calcium time was then subtracted off, leaving the same number of frames for both the 
behavior and calcium fluorescence. Grooming timestamps were transferred to a binary/continuous 
trace of the same length and sampling rate (10 Hz) as each calcium trace via logical indexing 
(grooming = 1, not-grooming = 0). Timestamps for behavior were converted to the closest 
matching frame in the calcium recording (maximum error of ± 100ms at 10 Hz). Calcium activity 
could then be aligned to the start and end of a grooming bout, or to the transition point between 
one grooming bout and another (when there was ≤ 1s between a grooming bout ending and a 
grooming bout beginning). 
2.1.7.1 Unbiased event-related activity classification  
A more precise method of analyzing calcium imaging data is assessing if the calcium activity of 
each individual cell is modulated by a behavioral event of interest (in this case, grooming). In this 
study, cells were categorized as activated by grooming-onset, inhibited by grooming-onset, or 
unaffected by grooming-onset. To quantitatively classify the grooming onset-responsiveness of 
each cell, we adapted a strategy used in (Jimenez et al. 2018) using custom Matlab 
(MATHWORKS) scripts. For each cell, we first aligned raw calcium fluorescence to the onset of 
each grooming bout. These traces were then averaged across all bouts within a given testing 
session. For each cell, we assessed raw calcium fluorescence for 10s prior to and 10s following 
grooming onset. Each instance of grooming-onset is defined as an individual trial, and trials are 
subdivided into 200 individual time bins at 10Hz (100ms per sample). Individual time bins were 
shuffled in time for each trial (200x) to remove any temporal information that was previously in 
each trace while maintaining the variance within each grooming bout. This shuffle was repeated 
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1000 times per cell to obtain a null distribution of grooming-associated calcium activity. A cell 
was classified as responsive to grooming onset if its Z-normalized calcium fluorescence amplitude 
between -0.5s before grooming onset to 3s after grooming onset exceeded ± 1 standard deviation 
threshold from the null distribution. If the average calcium signal of a cell exceeded +1 standard 
deviation of the shuffled average calcium signal, the cell was categorized as activated. If the 
average calcium signal of a cell exceeded -1 standard deviation of the shuffled average calcium 
signal, the cell was categorized as inhibited. Cells with calcium signal that fell within ± 1 standard 
deviation of the shuffled average calcium signal were determined to be unaffected by grooming 
onset (activity is not significantly modulating by grooming-onset). Individual cells classified as 
activated or inhibited by grooming onset could then be averaged across genotype and directly 
compared within and across sessions, providing an assessment of how cells encoding grooming 
differ across genotype or with drug treatment. 
2.1.7.2 Accurate cell matching across sessions 
Putative neurons were matched using a probabilistic modeling method detailed in (Sheintuch et al. 
2017). The cell matching occurred across two sessions and was performed using the following 
steps. First, centroid location for all cells were projected onto a single image. Slight rotation and 
translation difference between sessions were adjusted to achieve maximal cross-correlation 
between sessions. Probabilistic modeling was then employed to determine which model (centroid 
distance vs spatial correlation) was optimal for each set of data. For all data, the spatial correlation 
model yielded the best results and was thus used to match cells across sessions. For final alignment, 
the spatial correlation (not the joint model) was used, and correlation values for nearest neighbors 
was set at ≥ 0.70. 
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2.1.8  Statistical analysis 
Statistical analysis was carried out using custom Matlab scripts (MATHWORKS) or GraphPad 
Prism 8.0 (GraphPad Software, San Diego CA, USA). Throughout this thesis, results are reported 
as mean ± SEM unless otherwise noted.  
2.1.8.1 Statistical analysis of grooming behavior 
Baseline grooming behavior in Sapap3-KOs and WTs was analyzed using two-tailed independent 
samples t-tests. To analyze behavioral changes following fluoxetine administration, a two-way 
repeated measure analysis of variance (ANOVA) was used. Main effects and interaction terms are 
reported throughout, and in cases of significant interactions, post-hoc comparisons were made 
using Sidak’s multiple comparison correction. A corrected alpha was set to 0.05.  
2.1.8.2 Statistical analysis of calcium imaging data  
In order to evaluate the effect of genotype and treatment on grooming-evoked calcium 
fluorescence averaged across individual cells, unpaired two-tailed t-tests were performed at each 
time bin (100ms). Due to our high N with dozens to hundreds of cells in each condition, a 
conservative Bonferroni correction was performed at 𝛼 =  
0.05
𝑚
. The critical p value (α = 0.05) was 
divided by the total number of time bins (each bin = 100ms) to be compared (m), resulting in 
adjusted critical values between 0.00025 and 0.0005, depending on the exact comparison. 
For comparison of proportions of classified cells during baseline imaging sessions, two-
tailed independent samples t-tests were used. To assess the effect of fluoxetine treatment on the 
proportions of classified cells, two-way repeated measures ANOVA were used. When a significant 
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interaction between genotype and drug treatment was observed, post-hoc tests were conducted 
using Sidak’s multiple comparisons test. A corrected alpha was set to 0.05. 
2.1.9  Histology 
Following the completion of all experiments, animals were perfused with phosphate buffered 
saline (1X PBS) followed by 4% paraformaldehyde (PFA). Brains were extracted and post-fixed 
in 4% FPA for 24 hours. They were then transferred to a 30% sucrose azide solution for 24-48 
hours. Brains were sliced at -20ºC into 35µm slices using a Leica CM3050 cryostat, and slices 
were stored in wells containing a 1X PBS + .1% NaN3 solution. Slices were mounted onto slides 
from 1X PBS, cover-slipped with FluoroshieldTM with DAPI mounting medium and visualized 
using a scanning microscope at 10x magnification to confirm viral expression and proper lens 
placement in mouse central striatum as specified by Paxinos and Franklin’s The Mouse Brain in 





2.2 Experiment 2 (D1-cre Cohort) 
2.2.1  Subjects 
All procedures were conducted in accordance with the National Institute of Health’s Guide to the 
Care and Use of Laboratory Animals and approved by the University of Pittsburgh’s Institutional 
Animal Care and Use Committee. For Experiment 2, D1-cre positive x Sapap3-KO and D1-cre 
Sapap3-WT mice on 100% C57BL/6 background were generated by breeding D1-cre positive 
mice with heterozygous mutants (Sapap3+/-). Six adult (four male, two female) D1-cre x Sapap3-
KO mice and eight adult (three male, five female) D1-cre x Sapap3-WT mice were utilized in this 
experiment, and behavioral and neuronal data were collected from all animals. Each animal was 
housed on a 12-hour light cycle (lights on at 7AM), and mice were approximately 4-6 months old 
at the time of the first surgical procedure.  
Surgical procedures were identical to those described for Experiment 1 in Section 2.1.2 
with the exception of viral strain. For this experiment, mice were injected with 800nl of Cre-
dependent GCaMP6m (AAV9-Syn-Flex-GCaMP6m-WPRE-SV40, 2.7e13) into the central 
striatum (AP: +0.65mm, ML: -1.8mm, DV: -2.9 & -3.0mm). Injection of this D1-promoter virus 
allowed in vivo visualization of D1-SPNs. All behavioral protocols, drug treatment protocols, and 
behavioral and calcium imaging analysis performed in Experiment 2 were the same as in 
Experiment 1 (see Section 2.1 above for details).  
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3.0 RESULTS 
3.1 Experiment 1 Results (Synapsin Cohort) 
3.1.1  Sapap3-knockouts groom more than wild-types with microscope attached 
Previously it has been reported that Sapap3-knockout (KO) mice spend significantly more time 
grooming than wild-type (WT) littermates (Welch et al. 2007). Consistent with previous findings, 
we observed that the compulsive grooming phenotype of Sapap3-KOs is maintained following 
surgical implantation of a microendoscope and attachment of a 2-gram miniature microscope. 
Relative to WT littermates, Sapap3-KOs spent a significantly longer time engaged in grooming 
throughout a 40-minute testing session (Fig. 3.1A; t(8) = 4.84, p = .001), and Sapap3-KOs 















(A) Sapap3-KO mice spent significantly more time grooming during 40-minute testing session relative to WT mice. 
(B) Sapap3-KO mice initiated a significantly higher number of grooming bouts throughout the course of the session 







Figure 3.1 Total Grooming Time and Number of Grooming Bouts 
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3.1.2  Central striatum of Sapap3-KO mice is hyperactive during compulsive grooming 
After aligning behavioral activity with striatal calcium activity, we examined each individual cell’s 
response to the beginning of grooming behavior and averaged the response of each cell to all 
instances of grooming-onset that occurred throughout the 40-minute testing session to obtain Z-
normalized fluorescence of each cell at grooming onset. With an average of over 100 cells detected 
per animal, we then compiled each cell’s normalized calcium fluorescence at grooming onset in 
each group (WT and KO).  
Cells were sorted based on normalized fluorescence at grooming onset (t = 0), from greatest 
to least fluorescence. We displayed each cell’s normalized calcium fluorescence for a 10s-time 
frame surrounding grooming onset (5s prior to groom-start through 5s after groom-start), 
generating heat plots of normalized calcium fluorescence at grooming-onset within each group 
(Figure 3.2). In examining the respective heat plots for grooming-onset in the striatal cells of KOs 
and WTs, it is apparent that more cells from KO mice exhibit higher normalized calcium 
fluorescence at the onset of grooming, and this increased fluorescence appears to persist following 
grooming-onset. 
Next, we averaged normalized fluorescence of all cells within each group at each individual 
100ms time bin from 5s prior to through 5s following grooming-onset. These collapsed traces were 
compared across genotype using t-tests and corrected for multiple comparisons. In doing so, we 
found that normalized calcium fluorescence was significantly increased in the SPNs of KO mice 
relative to WT mice beginning at approximately 1s prior to grooming onset and persisting for 5s 
following grooming onset. (Figure 3.3; All significant values had t(733) ≥ 4.086 and  p ≤ .000049.) 
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 Normalized calcium fluorescence is plotted as a function of color and aligned to the onset of grooming behavior in 
Sapap3-KOs (Figure 3.2A) and WTs (Figure 3.2B). Data are depicted as the average fluorescence response evoked at 
the onset of grooming bouts, and neurons were sorted based on calcium fluorescence at time = 0ms (the instant a 
grooming behavior is initiated). Normalized fluorescence appears to be increased at and following grooming-onset in 
Sapap3-KOs, an effect not observed in WT mice. 
 
Figure 3.2 Heatplots of Normalized Calcium Fluorescence of Individual Cells to Grooming Onset 
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This figure shows the normalized fluorescence of all cells collapsed to generate composite traces for each Sapap3-
KOs and WTs. SPNs of Sapap3-KOs show a large transient increase in fluorescence in response to grooming onset 
that persists for several thousand milliseconds, and this effect is not observed in SPNs of WT mice. This suggests that 




Figure 3.3 Averaged Calcium Fluorescence Across All Cells at Grooming Onset 
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3.1.3  No significant difference in amplitude of grooming-modulated spiny projection 
neurons of Sapap3-KO and WTs 
Several underlying factors could contribute to our observation of increased calcium fluorescence 
at grooming onset in KOs relative to WT mice. One possibility is KOs and WTs may have equal 
numbers of groom onset-activated SPNs, but the amplitude of groom onset-activated SPNs in KOs 
is greater than the amplitude of groom onset-activated SPNs in WTs. This difference would be 
shown by greater normalized fluorescence at grooming onset in groom onset-activated SPNs of 
KOs relative to WTs.  Conversely, this effect could be observed if the amplitude of cells that are 
inhibited at grooming onset in KO mice significantly differs from that of WT mice. Specifically, 
if groom onset-inhibited SPNs in WT mice were inhibited to a stronger degree that groom onset-
inhibited SPNs of KOs, then normalized fluorescence at grooming onset in groom onset-inhibited 
SPNs of KOs would be elevated relative to normalized fluorescence at grooming onset in groom 
onset-inhibited SPNs of WT mice. 
To investigate these possibilities, we assessed if the amplitude of activity-modulated SPNs 
differed across genotype. We first categorized all SPNs in each group as activated, inhibited or 
unaffected by groom-onset using the strategy described in Section 2.1.7.1. After separating out all 
activated units in KOs and WTs, we averaged across all activated units within each genotype. We 
also separated out all inhibited units in KOs and WTs and averaged across all inhibited units within 
each genotype. When comparing the average amplitude of activated and inhibited units of KOs 
and WTs, we did not find any significant differences for either activated or inhibited SPNs across 
genotype. Within activated cells, the amplitude difference that was closest to significance was 
t(123) = 2.78, p = .0062 (Figure 3.4A). Within inhibited cells, the amplitude difference that was 
closest to significance was t(41) = 2.5693, p = .0139 (Figure 3.4B). 
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This figure shows the normalized calcium fluorescence of all cells that are modulated by grooming-onset in Sapap3-
KO and WT mice. (A) There is no significant difference in amplitude of groom onset-activated cells across genotype 
(all t(123) ≤ 2.78, all p ≥ .0062). (B) There is no significant difference in amplitude of groom onset-inhibited cells 
across genotype (all t(41) ≤ 2.57, all p ≥ .0139). Dashed gray lines represent error bars, showing the range of Z-scored 









Figure 3.4 No Difference in Amplitude of Grooming-Modulated Spiny Projection Neurons 
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3.1.4  Sapap3-KOs have more grooming onset-activated spiny projection neurons than WTs 
Given that we did not discover a difference in amplitude of grooming-modulated SPNs in Sapap3-
KOs relative to WTs, we hypothesized that the increased calcium fluorescence at grooming onset 
observed in KO mice was driven by a difference in the percentage of total SPNs that are positively 
or negatively modulated by grooming onset. Specifically, this difference could be the result of an 
increased percentage of groom onset-activated SPNs in Sapap3-KO mice relative to WT mice or 
a decreased percentage of groom onset-inhibited SPNs in Sapap3-KO mice relative to WT mice. 
Using the cell sorting methods described in Section 2.1.7.1, we assessed the activity-modulation 
of all SPNs in Sapap3-KOs and WTs. We found that a significantly higher percent of total SPNs 
were activated by grooming onset in Sapap3-KO mice relative to WT mice (Figure 3.5B; t(8) 
=4.846, p =.0013). There was no significant difference in the percentage of cells inhibited by 
grooming onset across genotype (Figure 3.5B; t(8) = .672, p = .5205). This finding indicates that 
the overall striatal hyperactivity that is observed in Sapap3-KOs at grooming onset may be due to 
the recruitment of a greater number of striatal SPNs at the initiation of a grooming behavior.  
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Figure 3.5 Grooming-Modulated Cell Populations 
(A) A representative sample of SPNs from one WT and one KO mouse that were identified as activated, inhibited, or 
unaffected by grooming onset. (B) A significantly higher percentage of groom onset-activated cells were observed in 
Sapap3-KOs relative to WT mice. There was no significant difference in the percentage of groom onset-inhibited 
SPNs across genotype. (*p < .05) 
A B 
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3.1.5  Fluoxetine reduces compulsive grooming in Sapap3-KO mice 
Previous studies report that the compulsive grooming phenotype of Sapap3-KO mice can be 
reversed by acute SSRI treatment (Welch et al. 2007). Here, we treated Sapap3-KO and WT mice 
with 5mg/kg FLX in a .9% saline solution (10mL/kg) injected i.p. daily for 7 consecutive days. 
We found that there was a main effect of genotype on time spent grooming (F(1,8) = 12.55, p = 
.0076) as well as a main effect of FLX treatment (F(1,8) = 13.71, p = .0060). Additionally, there 
was an interaction between genotype and FLX treatment (F(1,8) = 17.59, p = .0030). Post hoc 
comparisons showed that 7 days fluoxetine treatment significantly reduced time spent grooming 
in Sapap3-KO mice (Figure 3.6A; t(8) = 5.584, p = .0010) but not in WT mice (Figure 3.6A; t(8) 
= .3476, p = .9309). We also found a main effect of genotype on grooming bout number (F(1,8) 
= 3.941, p = .0824) as well as a main effect of FLX treatment (F(1,8) = 3.465, p = .0997) and an 
interaction between genotype and FLX treatment (F(1,8) = 3.465, p = .0997). Post hoc 
comparisons showed that 7 days of fluoxetine significantly reduced number of grooming bouts 
initiated by Sapap3-KO mice (Figure 3.6B; t(8) =2.633, p = .0592) but not WT mice (Figure 3.6B; 
t(8) = 0.0, p = 1.0). 
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(A) At baseline, Sapap3-KO mice spent a significantly longer time grooming in a 40-minute session relative to WT 
mice and initiated significantly more individual grooming bouts. Following 7 days of fluoxetine administration, 
grooming was significantly reduced in KO mice, but grooming levels of WT mice were unaffected. (B) At baseline, 
Sapap3-KO mice engaged in a significantly higher number of grooming bouts. After 7 days of fluoxetine 
administration, Sapap3-KO mice had a significant reduction in grooming bout number. These findings indicate that 
fluoxetine is capable of reducing compulsive grooming in Sapap3-KO mice and that drug administration does not 
affect activity of WT animals. (***p < .001, **p < .01) 




3.1.6  Fluoxetine reduces percentage of cells activated at grooming-onset in Sapap3-KO 
mice   
After observing a significant reduction in levels of compulsive grooming behavior in Sapap3-KO 
mice following 7 days of fluoxetine administration, we assessed in vivo calcium activity from 
experimental day 7 and compared with calcium activity data from baseline day of the experiment 
to investigate potential neural correlates of effective SSRI treatment. Following the same process 
described in Sections 2.1.7.1 and 2.1.7.2, we aligned cells across days and compared the activity 
of each SPN at the onset of a grooming bout on experimental baseline day and experimental day 
7. Only cells that were detected on both days of the experiment were included in subsequent 
analysis. 
Figure 3.7A shows the distribution of groom onset-modulated SPNs in a single animal at 
baseline and on day 7. After matching cells, we separated out all units that were activated at 
baseline and assessed their subsequent activity on day 7 in each group. We found that there was a 
main effect of genotype on percentage of activated cells on day 7 relative to baseline day (F(1,8) 
= 18.80, p = .0025) and a main effect of FLX treatment (F(1,8) = 7.8, p = .0235). There was also 
an interaction between genotype and FLX treatment (F(1,8) = 2.167, p = .1792). Post hoc 
comparisons showed that 7 days of FLX treatment significantly reduced percentages of activated 
cells on day 7 relative to baseline day in KO mice (Figure 3.7B; t(8) = 3.016, p = .0331) but not 
WTs (t(8) = .9339, p = .6127). 
When assessing the percentage of groom onset-inhibited cells in KOs and WTs at baseline 
and following 7 days of FLX treatment, there was no evidence for an effect of genotype or FLX 
treatment on the percentage of groom onset-inhibited cells (F(1,8) = .3836, p = .5529; F(1,8) = 
.3008, p = .5936). There was no interaction between genotype and FLX treatment on percentage 




(A) A representative sample of SPNs from the same KO mouse that were identified as activated by grooming onset 
on experimental baseline day. Of those found to be activated at baseline, some were found to be inhibited or unaffected 
by grooming onset after 7 days of fluoxetine treatment, while some cells maintained their categorization as grooming 
onset-activated SPNs. (B) At baseline, KO mice had a significantly higher percentage of groom onset-activated SPNs, 
relative to WT mice. Following 7 days of fluoxetine treatment, there was a significant reduction in the percentage of 
groom onset-activated SPNs in KO mice, while there was no significant change in the percentage of grooming-
modulated SPNs observed in WT mice. 7 days of fluoxetine treatment did not significantly alter the percentage of 
groom onset-inhibited SPNs in either group (*p < .05). 
A B 
Figure 3.7 Percent of cells activated or inhibited by grooming at baseline and following 7 days 
flouxetine treatment. 
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3.2 Experiment 2 Results (D1-cre Cohort) 
After observing overall hyperactivity within the striatum of Sapap3-KO mice relative to WT 
littermates at grooming onset, we were interested in investigating the activity of individual SPN 
subpopulations. In this experiment, we studied the grooming behavior of six D1-cre x Sapap3-
KOs and eight D1-cre x Sapap3-WTs before and after 7 days of fluoxetine treatment. During each 
testing session, we also recorded calcium imaging data to investigate the grooming-associated 
activity of D1-SPNs in each group. We hypothesized that the striatal hyperactivity observed at 
grooming onset in Sapap3-KOs observed in Experiment 1 was driven by increased gain of D1-
SPNs that would be evidenced by greater normalized fluorescence at grooming onset in D1-SPNs 












3.2.1  D1-cre x Sapap3-KO mice groom more than D1-cre x Sapap3-WT mice 
Previously it has been reported that Sapap3-KO mice spend significantly more time grooming than 
WT littermates (Welch et al. 2007). Here, we confirmed that crossing heterozygous Sapap3 
mutants (Sapap3+/-) with D1-cre mice does not alter the grooming phenotype of Sapap3-KOs. 
Relative to D1-cre x WT littermates, D1-cre x Sapap3-KOs spent a significantly longer time 
engaged in grooming throughout a 40-minute testing session (Fig3.8A; t(12) = 3.13, p = 0.0087), 
and Sapap3-KOs performed more individual grooming bouts that WT counterparts (Fig. 3.8B; 
t(12) = 2.991, p = 0.0113). 
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(A) D1-cre x Sapap3-KO mice spent significantly more time grooming during 40-minute testing session relative to 
WT mice. (B) D1-cre Sapap3-KO mice initiated a significantly higher number of grooming bouts throughout the 







Figure 3.8 Total Grooming Time and Number of Grooming Bouts  
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3.2.2  Altered amplitudes of grooming onset-modulated D1-SPNs in Sapap3-KOs relative to 
WT mice 
As explained in Section 3.1.3, several underlying factors could contribute to genotype differences 
in grooming-associated calcium activity. One possibility is that Sapap3-KOs and WTs have equal 
numbers of grooming-modulated D1-SPNs, but the amplitudes of these cells differ across 
genotype. To investigate this possibility, we assessed the amplitude of activity-modulated D1-
SPNs in each group. We categorized all D1-SPNs in each group as activated, inhibited, or 
unaffected by grooming-onset using the strategy described in Section 2.1.7.1. After separating out 
all activated units in Sapap3-KOs and WTs, we averaged across all activated units within each 
genotype. We also separated out all inhibited units in Sapap3-KOs and WTs and averaged across 
all inhibited units within each genotype. 
When comparing the average amplitude of activated units across genotype, we found that 
the amplitude of normalized fluorescence of groom onset-activated D1-SPNs was significantly 
reduced in Sapap3-KO mice relative to WT counterparts at grooming onset and for several 
hundred milliseconds afterward. For groom onset-activated D1-SPNs, all significant time bins had 
t-values ≥ 4.2051 and p-values ≤ 0.000040519 (Fig. 3.9A; critical value after adjusting for multiple 
comparisons using Bonferroni, p = 0.00005). When comparing the average amplitude of inhibited 
units of D1-cre x Sapap3-KOs and D1-cre x WTs, we found that the amplitude of normalized 
fluorescence of groom onset-inhibited D1-SPNs was significantly increased in Sapap3-KOs 
relative to WT littermates, beginning roughly 1s after grooming onset. For grooming onset-
inhibited D1-SPNs, all significant time bins had t-values ≥ 4.2134 and p-values ≤ 0.000046491 
(Figure 3.9B; critical value after adjusting for multiple comparisons using Bonferroni, p = 
0.00005). 
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This figure shows normalized calcium fluorescence of all D1-SPNs that are modulated by grooming-onset in D1-cre 
x Sapap3-KO and D1-cre x WT mice. (A) Z-scored fluorescence of groom onset-activated D1-SPNs of D1-cre x 
Sapap3-KO mice is significantly reduced relative to D1-cre x WT counterparts (bar indicates all t ≥ 4.2051 and p ≤ 
0.000040519). (B) Z-scored fluorescence of groom onset-inhibited D1-SPNs of D1-cre x Sapap3-KO mice is 
significantly increased approximately 1s after grooming initiation, relative to D1-cre x WT littermates (bar indicates 






Figure 3.9 Amplitude of normalized fluoresence of grooming onset-activated D1-SPNs and grooming 
onset-inhibited D1-SPNs in Sapap3-KOs and WTs  
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3.2.3  Sapap3-KO mice have more groom onset-inhibited D1-SPNs relative to WT 
littermates  
In addition to differences in amplitude of grooming-modulated SPNs in Sapap3-KO mice, we 
hypothesized that there was a difference in the percent of grooming onset-activated and grooming 
onset-inhibited SPNs in Sapap3-KOs relative to WT littermates (similar to our findings in 
Experiment 1). Using the cell sorting methods described in Section 2.1.7.1, we assessed the 
activity-modulation of all SPNs in each group. We found that a significantly higher percent of total 
D1-SPNs were inhibited by grooming onset in Sapap3-KO mice relative to WT mice (Figure 3.10; 
t(11) = 2.568, p = 0.0261). There was no significant difference in the percentage of D1-SPNs 



















A significantly higher percentage of groom onset-inhibited D1-SPNs were observed in Sapap3-KOs relative to WT 
mice. There was no significant difference in percentage of groom onset-activated D1-SPNs. (**p < .001) 
 
 
Figure 3.10 Grooming-Modulated D1-SPN Populations in Sapap3-KOs and WTs 
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3.2.4  Fluoxetine reduces compulsive grooming in D1-cre x Sapap3-KO mice 
Following the baseline day of Experiment 2 in which behavior and in vivo calcium activity were 
recorded from D1-cre x Sapap3-KO and D1-cre x WT mice throughout a 40-minute testing 
session, all mice received 5mg/kg fluoxetine (FLX) in a .9% saline solution (10mL/kg) injected 
i.p. daily for 7 consecutive days. After completion of 7 days of fluoxetine treatment, grooming 
behavior and in vivo calcium activity were recorded throughout a second 40-minute testing session.  
On day 7, we found that there was a main effect of genotype on time spent grooming 
(F(1,11) = 6.988, p = 0.0228) as well as a main effect of FLX treatment (F(1,11) = 9.469, p = 
0.0105). Additionally, there was an interaction between genotype and FLX treatment (F(1,11) = 
5.940, p = 0.0330). Post hoc comparisons showed that 7 days fluoxetine treatment significantly 
reduced time spent grooming in D1-cre x Sapap3-KO mice (Figure 3.11A; t(11) = 3.757, p = 
0.0063) but not in D1-cre x WT mice (Figure 3.11A; t(11) = 0.4710, p = 0.8753). We also found 
a main effect of genotype on grooming bout number (F(1,11) = 8.121, p = 0.0158) as well as a 
main effect of FLX treatment (F(1,11) = 5.467, p = 0.0393) and an interaction between genotype 
and FLX treatment (F(1,11) = 2.395, p = 0.1500). Post hoc comparisons showed that 7 days of 
fluoxetine significantly reduced number of grooming bouts initiated by D1-cre x Sapap3-KO mice 

















(A) At baseline, D1-cre x Sapap3-KO mice spent a significantly longer time grooming in a 40-minute session relative 
to D1-cre x WT mice and initiated significantly more individual grooming bouts. Following 7 days of fluoxetine 
administration, grooming was significantly reduced in D1-cre x Sapap3-KO mice, but grooming levels of D1-cre x 
WT mice were unaffected. (B) At baseline, D1-cre x Sapap3-KO mice engaged in a significantly higher number of 
grooming bouts relative to D1-cre x WT littermates. After 7 days of fluoxetine administration, D1-cre x Sapap3-KO 
mice had a significant reduction in grooming bout number. These findings indicate that fluoxetine is capable of 
reducing compulsive grooming in D1-cre x Sapap3-KO mice and that drug administration does not affect activity of 
D1-cre x WT animals (**p < .01, *p < .05). 
Figure 3.11 Grooming Time and Bout Number at Baseline and Following 
7 Days Fluoxetine Treatment 
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3.2.5  Minor increase in amplitude of groom onset-activated D1-SPNs of Sapap3-KOs 
following 7 days fluoxetine administration  
After observing a significant reduction in levels of compulsive grooming behavior in Sapap3-KO 
mice following 7 days of fluoxetine administration, we assessed in vivo calcium activity from D1-
SPNs on experimental day 7 to investigate potential neural correlates of effective SSRI treatment. 
Following the same procedure described in Section 2.1.7.1, we assessed the normalized 
fluorescence of all D1-SPNs in Sapap3-KOs and WTs at grooming onset. We compared the 
amplitude of normalized fluorescence of groom onset-activated and groom onset-inhibited D1-
SPNs on before and after 7 days of fluoxetine administration. Note that on this day, in contrast to 
in Experiment 1, all grooming-modulated SPNs were considered, rather than only assessing 
changes in SPNs that were modulated by grooming onset on the baseline day.  
We observed a significant increase in the amplitude of normalized fluorescence in groom 
onset-activated D1-SPNs in Sapap3-KOs (Fig. 3.12A; critical value after adjusting for multiple 
comparisons using Bonferroni, p = 0.00005), but no significant alterations in amplitude of 
grooming onset-activated D1-SPNs in WT animals. For grooming onset-activated D1-SPNs in 
Sapap3-KOs, all significant time bins had t(151) ≥ 4.1851, p ≤ 0.0000482. For grooming onset-
activated D1-SPNs in WTs, amplitude difference closest to significant was t(141) = 4.0643, p = 
0.0000797.  
The normalized fluorescence of grooming onset-inhibited D1-SPNs was unaffected by 
SSRI administration in both groups. For groom onset-inhibited D1-SPNs in Sapap3-KO mice, the 
amplitude difference closest to significance was t(122) = 3.467, p = 0.0007274. For groom onset-




This figure shows the normalized calcium fluorescence of all grooming-modulated D1-SPNs in Sapap3-KO and WT 
mice prior to and following 7 days fluoxetine administration. (A top) Following 7 days fluoxetine administration, 
there is a significant increase in amplitude of groom onset-activated D1-SPNs in Sapap3-KOs (bar indicates all t(151) 
≥ 4.1851, p ≤ 0.0000482). (A bottom) Fluoxetine treatment did not affect normalized fluorescence of groom onset-
inhibited D1-SPNs in Sapap3-KO mice (all t(122) ≤ 3.467, p ≥ 0.0007274). (B top) Fluoxetine treatment did not affect 
normalized fluorescence of groom onset-activated D1-SPNs in WT mice (all t(141) ≤ 4.0643, p ≥ 0.0000797).   
(B bottom) Fluoxetine treatment did not affect normalized fluorescence of groom onset-inhibited D1-SPNs in WT 
mice (all t(95) ≤ 3.260, p ≥ 0.000965).  
Figure 3.12 Amplitudes of Grooming-Modulated D1-SPNs Following 7 Days 
Fluoxetine Administration 
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3.2.6  Fluoxetine does not alter percentages of grooming-modulated D1-SPNs in Sapap3-
KOs or WTs  
In addition to comparing the amplitudes of grooming-modulated D1-SPNs following 7 days of 
fluoxetine administration, we investigated potential changes in the percentage of groom-onset 
activated and inhibited D1-SPNs across genotype after FLX treatment. As described in Section 
2.1.7.1, we assessed the normalized fluorescence of all D1-SPNs at grooming onset on the 
experimental baseline day and experimental day 7. 
When assessing the percentage of grooming onset-activated D1-SPNs following 7 days of 
fluoxetine treatment, there was no evidence for an effect of genotype or FLX treatment on the 
percentage of activated cells (F(1,11) = 0.4483, p = 0.5170; F(1,11) = 1.381, p = 0.2648). There 
was no interaction between genotype and FLX treatment on percentage of activated cells (F(1,11) 
= 0.8773, p = 0.3691).  
When assessing percentages of grooming onset-inhibited D1-SPNs in Sapap3-KOs and 
WTs following 7 days fluoxetine treatment, we found that there was a main effect of genotype 
(F(1,11) = 5.211, p = 0.0043). There was no evidence for an effect of FLX treatment (F(1,11) = 
0.5344, p = 0.480). There was no interaction between genotype and FLX treatment (F(1,11) = 


















At baseline and following 7 days fluoxetine treatment, Sapap3-KO mice had a significantly higher percent of groom-
onset inhibited D1-SPNs relative to WT mice. There was no effect of genotype of FLX treatment on percent of groom-
onset activated D1-SPNs  (**p < .001).  




In the present study, we sought to investigate the neural underpinnings of compulsive behaviors 
and to assess how successful SSRI treatment alters neural activity and behavior in vivo. We found 
that relative to WT counterparts, Sapap3-KO mice spent a significantly longer time grooming and 
engaged in a significantly higher number of grooming bouts in a 40-minute testing session. 
Following 7 days of fluoxetine treatment, grooming time and bout number were significantly 
reduced in Sapap3-KOs but unaffected in WTs. Using in vivo calcium imaging in this cohort, we 
observed a significant increase in normalized fluorescence in SPNs of Sapap3-KOs at grooming 
onset that was not observed in SPNs of WT mice. After categorizing all SPNs in each group as 
groom onset-activated, groom onset-inhibited, or groom onset-unaffected, we found that this effect 
was driven by recruitment of a greater number of groom onset-activated SPNs in Sapap3-KO mice 
compared to WT mice. Following 7 days of fluoxetine treatment, there was a significant reduction 
in the percent of groom onset-activated SPNs in Sapap3-KOs, while percentage of grooming-
modulated SPNs was unchanged in WT mice. 
After studying the combined activity of D1- and D2-SPNs in vivo, we specifically 
investigated the grooming-associated calcium activity of D1-SPNs using D1-cre x Sapap3-KO 
mice and D1-cre x WT mice. In this cohort, Sapap3-KO animals again spent a significantly longer 
time grooming and engaged in a significantly higher number of grooming bouts relative to WT 
mice, and this compulsive grooming behavior was significantly reduced in Sapap3-KO animals 
following 7 days of fluoxetine administration. Surprisingly, upon investigating in vivo activity of 
D1-SPNs at grooming onset, we observed a significant reduction in activity of D1-SPNs in 
Sapap3-KOs relative to WTs as measured by normalized calcium fluorescence. This striatal 
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hypoactivity could be explained by our observation of decreased amplitude of groom onset-
activated D1-SPNs and an increase in the percent of groom onset-inhibited D1-SPNs. While 
compulsive grooming behavior was significantly reduced in Sapap3-KOs following 7 days of 
fluoxetine treatment, treatment had minor effects on D1-SPN activity. We observed a small, yet 
significant increase in normalized calcium fluorescence of groom onset-activated D1-SPNs in 
Sapap3-KOs, but no significant changes in the percent of grooming-modulated D1-SPNs in either 














4.1 Synthesizing Findings with Existing Literature 
Our observations of baseline striatal hyperactivity at groom onset that was normalized following 
fluoxetine treatment in Sapap3-KO mice are consistent with previous reports that implicate the 
striatum in compulsive grooming in Sapap3-KOs. Specifically, it has been shown that Sapap3-
KOs that received injection of a lentiviral vector that expressed GFP-SAPAP3 fusion protein in 
striatum on postnatal day 7 did not develop a compulsive grooming phenotype (Welch et al. 2007), 
suggesting that expression of SAPAP3 in striatum alone is sufficient to relieve the compulsive 
grooming that normally develops in Sapap3-KO mice. 
In another study, synaptic transmission of SPNs was examined in Sapap3-KO mice through 
ex vivo electrophysiological recordings. AMPAR-mediated excitatory transmission in Sapap3-
KOs was significantly reduced relative to WT littermates, but no differences in the presynaptic 
release probability of striatal SPNs were observed across genotype (Wan, Feng, and Calakos 
2011). This lack of difference in presynaptic properties also points to striatal dysfunction in 
Sapap3-KOs, rather than upstream abnormalities.  
As the striatum receives excitatory inputs from cortex and thalamus that differentially 
contribute to behavior (Wan et al. 2014; Pennartz et al. 2009), a follow-up study assessed AMPAR 
activity in corticostriatal and thalamostriatal synapses in Sapap3-KO mice to investigate if the 
striatal alterations observed in Sapap3-KOs is circuit-selective. Here, they found corticostriatal 
synaptic deficits but not thalamostriatal synaptic deficits in SPNs of Sapap3-KO mice and showed 
that SPNs have differential composition of SAPAP proteins at postsynaptic densities according to 
neural circuitry (corticostriatal vs thalamostriatal circuit) (Wan et al. 2014). These findings suggest 
that corticostriatal dysfunction driven by postsynaptic alterations underlies the compulsive 
grooming phenotype of Sapap3-KOs. Further support for this idea stems from recently published 
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work from our lab (Corbit et al. 2019), which demonstrates post-synaptic strengthening of inputs 
from M2 to central striatum in Sapap3-KOs using ex vivo electrophysiology. Additionally, in vivo 
electrophysiological recording showed a significant elevation in the baseline firing rates of striatal 
SPNs in Sapap3-KOs relative to WT littermates (Burguiere et al. 2013). 
Building on this past work, we expanded upon the finding of baseline striatal hyperactivity 
in Sapap3-KOs to determine the temporal relationship between increased striatal activity and 
compulsive grooming behavior. Using in vivo calcium imaging, we demonstrated a significant 
increase in normalized fluorescence of the combined population of D1- and D2-SPNs in Sapap3-
KO mice at grooming onset. Further, we demonstrated that this overall elevation in SPN activity 
was comprised of increased recruitment of SPNs activated at grooming onset in Sapap3-KO mice 
(as opposed to increased amplitude of groom onset-activated SPNs), a finding that was previously 
difficult to observe given the lower yield of cells captured using traditional electrophysiological 
recordings (e.g. 76-105 total units across all mice in central striatum (Burguiere et al. 2013), 
compared to over one hundred units per mouse on average in the present studies). 
The literature predicts that an increase in overall striatal gain contributes to habit formation 
and expression (O'Hare et al. 2016; Cui et al. 2013), which has long been hypothesized to be 
involved in the pathophysiology of OCD (Graybiel and Rauch 2000). Specifically, it has been 
hypothesized that this increase in striatal gain hastens action onset at the cost of increasing outcome 
errors (Cui et al. 2013). Reinforcement of initially healthy habits under maladaptive conditions can 
lead to the development of compulsions, such as those performed by patients with OCD. Given 
the temporal link between habit expression and increased striatal gain in healthy conditions, it is 
possible that a further increase in striatal gain could drive the initiation of compulsive behaviors, 
consistent with the findings of the present study. However, it is important to note that most work 
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investigating the link between striatal gain and habit formation has focused on corticostriatal 
circuits that encompass the medial prefrontal cortex (mPFC) and medial striatum (Smith et al. 
2012), which is located adjacent to the central striatum. It is currently unclear what, if any, role 
the central striatum plays in encoding habit formation, but we can speculate that increased central 
striatal gain in Sapap3-KOs may contribute to the formation of habitual (and ultimately 
compulsive) behaviors in a similar manner to what has been described in other sub regions of 
striatum, i.e. medial striatum and dorsolateral striatum.  
An outstanding question leading from this work is: How is the striatal hyperactivity we 
observed at grooming onset, which is specifically characterized by an increase in the number of 
activated cells, generated at a circuit level? Spiny projection neurons comprise approximately 95% 
of striatal neurons, and the remaining 5% of striatal neurons are inhibitory interneurons (Blomeley 
and Bracci 2009). One subclass of striatal inhibitory interneurons is GABAergic parvalbumin-
positive (PV+) fast-spiking interneurons (FSIs). While FSIs represent less than 1% of all striatal 
neurons, their influence on the activity of spiny projection neurons is outsized (Berke 2011). 
Relative to SPNs, FSIs receive convergent inputs from a wider range of cortical regions and are 
more responsive to these inputs. As their name suggests, fast-spiking interneurons respond to this 
cortical input with brief, high-frequency bursts of activity, synapsing onto the soma or proximal 
dendrites of neighboring SPNs (Berke 2011). This stochastic GABAergic input onto many 
surrounding SPNs creates widespread feedforward inhibition of striatal activity. Because of the 
basal ganglia’s critical role in action selection, this feedforward inhibition may enable selection of 
favorable actions while suppressing incompatible alternative actions (Owen, Berke, and Kreitzer 
2018).  
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Evidence from the literature also supports the converse idea- i.e., weakening this 
feedforward inhibition onto SPNs could result in aberrant striatal activity and an inability to 
efficiently select an adaptive action. First, losing FSIs (and their associated inhibition of SPNs) 
has been associated with disorganized behavioral output. Specifically, several post-mortem studies 
have reported that, relative to healthy comparison subjects, there is a significant reduction (50-
60%) in the number of PV+ interneurons in the striatum of patients with severe Tourette syndrome 
(TS) – a neuropsychiatric illness associated with motor and vocal tics that has a high incidence of 
comorbidity with OCD (Kataoka et al. 2010; Kalanithi et al. 2005). Preclinical studies have also 
suggested a role for FSIs in repetitive behaviors. In an attempt to recapitulate the anatomical 
changes observed in post-mortem tissue from TS patients, (Xu, Li, and Pittenger 2016) performed 
targeted ablation of striatal FSIs in mice. To remain as consistent with post-mortem literature as 
possible, they ablated roughly 50% of FSIs in dorsal striatum. They found a significant increase in 
performance of stress-induced grooming behavior in PV-ablated mice relative to control animals, 
indicating that reducing FSI activity is sufficient to increase repetitive grooming in mice (Xu, Li, 
and Pittenger 2016). Another study found that selective inhibition of striatal FSIs via local infusion 
of a GABA antagonist led to dyskinetic behavior in mice (Gittis et al. 2011). Interestingly, this 
selective FSI inhibition resulted in increases and decreases in striatal SPN firing rates, supporting 
the notion that striatal FSIs are responsible for coordinating the activation of striatal SPNs for 
adaptive action selection, rather than strictly inhibiting neighboring SPNs (Gittis et al. 2011). 
Similarly, a recent study showed that both optogenetic suppression and over-activation of striatal 
FSIs disrupted performance of reward anticipatory behavior (licking), indicating that under 
physiological conditions, FSIs modulate SPN activity to enhance behavioral performance (Lee et 
al. 2017).   
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In 2013, (Burguiere et al. 2013) observed a significant reduction in the number of striatal 
FSIs in Sapap3-KO mice relative to WT littermates and utilized optogenetics to examine if this 
loss of striatal feedforward inhibition played a causal role in the production of a compulsive 
grooming phenotype in Sapap3-KO mice (but see (Corbit et al. 2019) where no differences in PV+ 
cell numbers are observed between Sapap3-KOs and WTs). To do so, they optogenetically 
stimulated axon terminals from the lateral OFC (lOFC) in centromedial striatum and recorded from 
FSI-SPN pairs. Stimulation of ChR2-containing lOFC axon terminals resulted in a significant 
increase in activation of FSIs and subsequent increased inhibition of SPNs (Burguiere et al. 2013). 
Critically, they showed that lOFC axon terminal stimulation could rescue the compulsive 
grooming phenotype of Sapap3-KO mice. Compared to control Sapap3-KO animals injected with 
YFP, ChR2 stimulation of lOFC terminals in Sapap3-KO mice led to a significant reduction in 
grooming during laser on periods relative to laser off periods (Burguiere et al. 2013). Based on 
these findings, one possible explanation for the striatal hyperactivity we observed in Sapap3-KOs 
at grooming onset is a decrease in feedforward inhibition from neighboring FSIs.  
Consistent with this prediction, unpublished work from the Ahmari lab indicates that in 
lOFC there is a significant reduction in normalized calcium fluorescence at grooming onset in 
Sapap3-KO mice relative to WT littermates. Specifically, this broad reduction in lOFC activity 
appears to be driven by an increase in the percentage of grooming onset-inhibited cells in Sapap3-
KO animals. To complement these findings, a recent study from our lab showed that ex vivo 
optogenetic activation of lOFC terminals in WT mice resulted in preferential activation of striatal 
FSIs over SPNs (Corbit et al. 2019). With these data in mind, it is reasonable to speculate that 
striatal hyperactivity in Sapap3-KO mice at grooming onset is evoked by decreased lOFC 
activation of striatal FSIs, resulting in disinhibition of striatal spiny projection neurons. 
 60 
4.1.1  Fluoxetine affects striatal activity in vivo 
In addition to observing striatal hyperactivity in vivo in Sapap3-KO mice, we found that 7 days of 
fluoxetine treatment normalized striatal activity in Sapap3-KOs on the same timescale as 
behavioral normalization. It is currently unclear how fluoxetine affects corticostriatal circuitry in 
vivo. However, our findings are consistent with previous reports indicating that serotonin directly 
influences neuronal excitability. In one study, bath application of serotonin to rat brain slices 
strongly increased the excitability of striatal FSIs relative to control conditions (Blomeley and 
Bracci 2009). This effect was mediated by serotonin acting on the 5-HT2C receptor that is highly 
expressed on FSIs. In a separate study, the effect of fluoxetine on FSI excitability was assessed 
directly. Firing rates of PFC FSIs and pyramidal neurons were recorded prior to and following 
bath application of fluoxetine to slices of rat cortex. Fluoxetine significantly increased single-cell 
firing rates of PFC FSIs in a dose-dependent manner but did not impact pyramidal cell firing rates 
(Zhong and Yan 2011). Furthermore, unpublished data from the Ahmari lab shows that single-cell 
firing rates of striatal FSIs are significantly increased following bath application of fluoxetine 
(Corbit, Gittis, & Ahmari, unpublished observations). 
Considering this evidence, one rational explanation of the current findings is that fluoxetine 
decreases striatal activity at grooming onset by increasing the excitability of striatal FSIs. FSIs are 
then able to re-exert their modulatory influence on neighboring SPNs, restoring normal patterns of 
striatal activity. While further studies must be conducted to uncover the precise pharmacological 
mechanisms of SSRIs such as fluoxetine, the results of the present study provide support for the 
hypothesis that SSRIs effectively reduce maladaptive, aberrant behaviors by reestablishing the 
feedforward inhibition of FSIs onto SPNs in the striatum. 
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4.1.2  D1- and D2-SPN contributions to compulsive behaviors 
Through the “direct pathway” of basal ganglia circuitry, D1-SPNs disinhibit the thalamus, 
enabling thalamus to send excitatory projections to cortex to direct the execution of movements, 
As Sapap3-KO mice groom excessively, we hypothesized that the overall striatal hyperactivity 
observed in Experiment 1 was driven by increased D1-SPN activity at grooming onset in Sapap3-
KOs. Specifically, it is well-established that activating D1-SPNs with the dopamine 1 receptor 
agonist SKF induces excessive grooming in rodents in a dose-dependent manner (Stoessl 1994; 
Page SJ 1997; Deveney AM 1995). Furthermore, we speculated that the overall hyperactivity 
observed in Sapap3-KO mice may be driven by reduced input from striatal FSIs. A recent study 
conducted ex vivo electrophysiological recordings in striatal FSIs that synapsed onto D1- and D2-
SPNs. They found that a significantly higher percent of FSI→D1-SPN pairs were functionally 
connected compared to FSI→D2-SPN pairs (Gittis et al. 2010). This apparent bias of FSI 
feedforward inhibition onto D1-SPNs also led us to hypothesize that D1-SPNs are responsible for 
the overall striatal hyperactivity observed in Sapap3-KO mice. Additionally, results of in vivo 
electrophysiological recordings in striatum of Sapap3-KO and WT mice show a shift in striatal 
output favoring the direct (D1) pathway in Sapap3-KO mice relative to WTs, providing further 
evidence that increased D1-SPN drive underlies the compulsive grooming behavior observed in 
Sapap3-KO mice (O'Hare et al. 2016). Finally, there have been several ex vivo electrophysiology 
studies from animal models supporting the idea that excessive activity in D1-SPNs is related to 
the development of abnormal repetitive behaviors. However, the results of Experiment 2 were not 
consistent with this hypothesis, because we observed a significant reduction in activity of D1-
SPNs of Sapap3-KOs relative to WTs that was driven by an increased percentage of groom onset-
inhibited D1-SPNs. 
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Given the findings of Experiments 1 and 2 presented in this thesis, it is likely that D2-SPN 
hyperactivity is responsible for the overall grooming-associated striatal hyperactivity observed in 
Sapap3-KO mice. While this may initially seem counterintuitive, several studies indicate that D2-
SPN activity may be more relevant to the generation of compulsive behaviors than previously 
assumed. A recent study conducted by (Rothwell et al. 2015) investigated the role of direct and 
indirect corticostriatal pathways in behavioral performance on a serial order task. Optogenetic 
stimulation of D2-SPNs in DLS led to a decrease in the percentage of correct serial order trials, 
and optogenetic inhibition of D2-SPNs resulted in significant improvements in accurate 
completion of the task (Rothwell et al. 2015). Critically, D2-SPN stimulation did not alter the 
latency of responding, which contradicts the classical model that asserts that D2-SPN activation 
results in inhibition of movements, and specific studies that show optogenetic stimulation of D2-
SPNs impedes movement (Kravitz et al. 2010). As Sapap3-KO mice display abnormally high 
levels of grooming behavior, it is possible that concomitant D2-SPN hyperactivity is responsible 
for this phenomenon.  
Additional support for D2-SPN involvement in compulsive behaviors comes from clinical 
studies. Compared to healthy comparison subjects, OCD patients have decreased D2 receptor 
availability in striatum prior to receiving pharmacological treatment (Moresco et al. 2007). 
Decreased receptor availability likely results from increased activation of D2-SPNs and 
compensatory endocytosis of receptors. Following twelve weeks of treatment with the SSRI 
fluovamine, all but one OCD patient (from a group of 9 individuals) showed significant 
improvement in symptoms. Critically, PET scans showed that treatment responsive individuals 
had a significant increase in the D2 receptor availability in the striatum (Moresco et al. 2007). 
These findings provide further evidence that D2-SPN hyperactivity may be implicated in the 
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compulsive symptoms associated with OCD and lead us to hypothesize that striatal hyperactivity 
observed in Sapap3-KO mice during compulsive grooming is primarily driven by excessive D2-













4.2 Methodological Limitations 
While the findings presented in this thesis provide novel insight into the neural correlates of 
compulsive behaviors, further investigation must be performed to more completely resolve the 
circuit-level mechanisms underlying compulsive grooming in our animal model. In particular, it is 
difficult to make strong claims regarding the cell-type specificity of grooming-associated striatal 
hyperactivity that we observed in Sapap3-KO mice without assessing the activity of D2-SPNs in 
vivo. Because generating double-transgenic mouse lines is a time-intensive process, we have made 
several attempts to investigate the in vivo calcium activity of D2-SPNs while breeding up a colony 
of A2A-cre x Sapap3-KO and A2A-cre Sapap3-WT mice.  
First, we attempted to utilize a D2-specific promoter GCaMP6m virus (AAV8-D2R-
GCaMP6m) to specifically label D2-SPNs in Sapap3-KOs. This virus was developed by the 
Deisseroth Lab in 2016 by cloning the D2-specific promoter fragment from rat genome, found 
immediately upstream of the D2 receptor gene (Zalocusky 2016). Because there has been no 
published use of this virus in mice, we first wanted to confirm D2-specific viral expression. To do 
so, we injected 800nl of this D2-GCaMP6m into central striatum of D1-tdTomato mice that 
express red fluorescent protein (RFP) in all D1 receptor-expressing SPNs. If this virus was truly 
D2-specific, we hypothesized that we would not observe colocalization of RFP and GFP in 
striatum of D1-tdTomato mice that received viral injection. We followed the same surgical 
procedures for surgery 1 described in Section 2.1.2, and waited four weeks to allow sufficient viral 
transfection. At this point, mice were sacrificed, and tissue was perfused for further analysis. I 
carefully examined 35µm slices that had been enhanced for GFP using immunohistochemistry 
under a confocal microscope. As hypothesized, we did not observe colocalization of RFP and GFP, 
suggesting that this virus is indeed specific for D2-SPNs.  
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(A) Merged image of RFP channel (showing all D1-SPNs) and GFP channel (showing SPNs infected with D2-SP-
GCaMP virus). (B) RFP channel, showing all D1-SPNs. (C). GFP channel, showing all SPNs infected with D2-SP-
GCaMP virus. We observed negligible RFP and GFP colocalization, indicating that the D2-SP-GCaMP virus is 
specific for D2-SPNs in mice.  
 
 
While it was reassuring to observe viral specificity, we found that the efficacy of this virus 
for in vivo calcium imaging in mice was limited. Upon attaching the miniature microscope to 
surgerized animals to visualize in vivo calcium fluorescence from D2-SPNs, we unfortunately 
observed dim fluorescence that limited our ability to localize many individual SPNs. Over the 
course of several additional weeks we reassessed calcium fluorescence in these animals to ensure 
that our initial observations were not simply the result of insufficient viral transfection, but the 
calcium signal did not improve. Given these findings, this approach could not be used to achieve 
our experimental goal of assessing activity-related calcium activity of D2-SPNs in vivo. 
After failing to observe sufficient in vivo calcium fluorescence from D2-SPNs with the D2-
specific promoter GCaMP6m virus, we pursued an alternative strategy. As described in Section 
1.1.3.1, the output structures of D1- and D2-SPNs diverge, forming the canonically-described 




direct and indirect pathways of the basal ganglia. D1-SPNs specifically project to the internal 
segment of globus pallidus (GPi) and substantia nigra pars reticulata (SNr), while D2-SPNs project 
to the external segment of globus pallidus (GPe). Therefore, D2-SPNs could be specifically 
infected by injecting a retrograde GCaMP7 virus into the GPe. To assess the efficacy of this 
approach, I injected a retrograde GCaMP7 virus (retro-AAV-hSyn-GCaMP7, 1.85e13, addgene 
104488) into the GPE of WT mice and waited a minimum of 5 weeks for the virus to be transported 
to D2-SPN cell bodies in the striatum. After 5 weeks, animals were sacrificed, and tissue was 
perfused. Brains were sliced at -20ºC into 35µm slices using a Leica CM3050 cryostat. Slices were 
mounted onto slides, cover-slipped with FluoroshieldTM DAPI mounting medium and visualized 
using a scanning microscope at 10x magnification. Surprisingly, in spite of consistent viral 
targeting of GPe, we did not see any GFP expression in striatum. We have therefore not been able 
to successfully visualize in vivo calcium activity of D2-SPNs with this experimental strategy. We 
look forward to complementing the investigation of D1-SPN activity presented in this thesis with 
an in vivo calcium imaging study in A2A-cre x Sapap3-KO and A2A-cre x Sapap3-WT mice in 





(A) Scanning microscope image at 10x magnification of striatum 5 weeks after retro-GCaMP7 injection into GPe. (B) 
Scanning microscope image at 10x magnification of GPe 5 weeks after retro-GCaMP7 injection into GPe. In spite of 
consistent viral targeting of GPe, we did not observe viral expression in striatum, a target input structure of GPe. 
 
In the present study, we were limited in the number of groups we could include in each 
experiment. In particular, these experiments would have benefitted from having one additional 
group of each genotype that received vehicle injections of .9% saline instead of fluoxetine 
injections. It is possible that animals groomed less following 7 days of fluoxetine administration 
simply because they became more comfortable with experimenters after being scruffed and 
handled for 7 consecutive days. Comparing the behavior of Sapap3-KO + fluoxetine and Sapap3-
KO + vehicle on day 7 would allow us to assess this possibility and could be insightful in guiding 
accurate interpretation of our data.  
While we did not have vehicle groups, we recorded behavioral activity and in vivo calcium 
activity two weeks after the completion of fluoxetine treatment. Previous studies report 
comparable levels of grooming in Sapap3-KOs after two weeks of fluoxetine washout with 
Figure 4.2 Representative Image of Striatum and GPe after Injection of Retro-GCaMP7 
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Sapap3-KOs that received vehicle treatment in place of fluoxetine (Ahmari et al. 2013). These 
data indicate that assessing behavioral and neural activity after a two-week washout period is a 
useful measure to consider in the absence of additional vehicle groups. However, even after 
analyzing the results of a two-week washout test, we cannot be certain that the effects we observe 
are necessarily caused by fluoxetine treatment rather than additional factors such as greater 
habituation to experimenters and behavioral conditions. Until our studies can be replicated with 
additional vehicle groups, we must consider the additional variables that could have contributed 













4.3 Future Directions 
The current work suggests several directions of future research. First and foremost, it is important 
to investigate the grooming-associated activity of D2-SPNs in Sapap3-KO and WT mice to 
complement the studies of D1-SPNs described in this thesis. We are currently breeding A2A-cre 
x Sapap3-KO and A2A-cre x Sapap3-WT mice, and we intend to perform surgeries on the first 
cohort in the coming months in order to directly assess the activity of D2-SPNs in vivo.  
After completing thorough investigation of SPN activity in Sapap3-KO and WT mice, the 
next logical step is to examine the grooming-associated activity of striatal FSIs in Sapap3-KOs 
and WTs using in vivo calcium imaging. This will be achieved by injecting a Cre-dependent 
GCaMP6m virus (AAV-Syn-Flex-GCaMP6m-WPRE-SV40, 2.7e13) into striatum of PV-cre x 
Sapap3-KO and PV-cre x Sapap3-WT mice so that GCaMP will only be expressed in PV-positive 
cells. The surgical procedures will be similar to those described in this thesis with some minor 
modifications to account for the small population size of striatal FSIs (less than 1% of all striatal 
neurons). Specifically, we will implant a 1mm GRIN lens to maximize the number of FSIs we can 
image. Based on the findings presented in this thesis and our lab’s work investigating in vivo 
calcium activity in lOFC of Sapap3-KO and WT mice, I hypothesize that normalized calcium 
fluorescence in FSIs at grooming onset will be reduced in Sapap3-KO mice relative to WT 
counterparts and that 7 days of fluoxetine administration will significantly increase calcium 
activity of Sapap3-KO FSIs at grooming onset. While it will be technically challenging to image 
from striatal FSIs in vivo, investigating grooming-associated FSI activity in Sapap3-KOs and WTs 
will provide informative confirmation or refutation of our working hypothesis that the striatal 
hyperactivity observed in Sapap3-KO mice is driven by a reduction of FSI feedforward inhibition 
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onto SPNs. In either case, these findings will bolster our understanding of how aberrant CTSC 
activity contributes to behavioral compulsivity. 
In recent months, our lab has investigated the causal relationship between striatal 
hyperactivity and compulsive grooming using optogenetic stimulation of central striatal cell 
bodies. In this study, we utilized only WT mice. Animals were assigned to either an experimental 
or control group, receiving an injection of channelrhodopsin (ChR-2) or YFP in striatum. By 
intermittently stimulating CS cell bodies with blue light pulses, we see a significantly higher 
probability of grooming during light-on trials in ChR-2 mice compared to YFP mice. These data 
indicate that we can recapitulate grooming behavior by directly increasing striatal activity. I am 
interested in building upon these findings by performing a complementary experiment in Sapap3-
KO mice using an inhibitory opsin, halorhodopsin, in place of channelrhodopsin. In this 
experiment, animals will either receive an injection of halorhodopsin or YFP into striatum. Given 
my findings thus far, I hypothesize that intermittently inhibiting central striatal cell bodies will 
significantly reduce probability of grooming during light-on trials in Sapap3-KO mice. Further 
optogenetic manipulation of this circuitry in Sapap3-KO and WT mice will allow us to make 
stronger claims about the causal relationship between circuit-level abnormalities in striatum and 
compulsive behavior that can only be inferred from in vivo calcium imaging studies.  
Ultimately, I hope to attain comprehensive answers to the scientific questions posed in the 
Ahmari lab by combining in vivo calcium imaging and optogenetics. In (Burguiere et al. 2013), 
stimulation of lOFC axon terminals in striatum of Sapap3-KO animals significantly reduced 
probability of grooming during light-on trials. The authors hypothesized that this effect was caused 
by increased lOFC excitation of striatal FSIs and subsequent inhibition of striatal SPNs. However, 
this was not observed directly. Using new Inscopix nVoke technology that enables simultaneous 
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optogenetic manipulation and in vivo calcium imaging, the mechanism underlying this effect can 
be investigated in a more definitive manner. By injecting a red-shifted opsin such as Chrimson 
(Klapoetke et al. 2014) in lOFC and a Cre-dependent GCaMP6m virus (AAV9-Syn-Flex-
GCaMP6m-WPRE-SV40, 2.7e13) in striatum of PV-cre x Sapap3-KO, I will directly observe the 
effect of lOFC axon terminal stimulation on FSI activity. Based on the findings of (Burguiere et 
al. 2013) and the supportive data that I have generated in this thesis, I hypothesize that lOFC 
terminal stimulation will decrease the probability of grooming during light-on trials in PV-cre x 
Sapap3-KO mice. Additionally, I hypothesize that lOFC stimulation will result in increased 
calcium fluorescence from striatal FSIs. A similar approach could be utilized in D1-cre x Sapap3-
KO mice and A2A-cre x Sapap3-KO mice to investigate the effect of lOFC stimulation on D1- 
and D2-SPN activity. These experiments will provide deeper insight into the findings presented in 









4.4 Impact of Current Work  
Despite the severity and high prevalence of obsessive compulsive disorder (OCD), there is limited 
understanding of the precise mechanisms underlying this disease. Coupled with this, current 
treatment methods for OCD have limited efficacy with only 25% of patients achieving full 
remission with the first line pharmacologic treatment (Goddard et al. 2008). Neuroimaging studies 
have consistently reported structural and functional abnormalities in CSTC circuits in OCD (Piras 
et al. 2015; Pujol et al. 2004; Rotge et al. 2009; Rauch 1994; Saxena 1999), but it is difficult to 
investigate neural circuit mechanisms in human subjects. Instead, we turn to translational animal 
models. Sapap3-KO mice provide a particularly useful model for investigating the circuit-level 
abnormalities that may underlie OCD symptoms. These mice display a compulsive grooming 
phenotype and abnormalities in corticostriatal neurotransmission. In addition, the compulsive 
grooming phenotype of Sapap3-KOs responds to fluoxetine treatment, making them a useful 
model for investigating how effective SSRI treatment influences neural activity in CSTC circuits. 
OCD is a heterogeneous disorder that undoubtedly cannot be simplified to altered expression of a 
single gene. With this in mind, it is interesting to note that in the first post-mortem study of 
differential gene expression in OFC and striatum of OCD subjects and matched comparison 
subjects, expression of the DLGAP3 gene (synonymous with Sapap3 in mouse genome) was 
significantly decreased both OFC and striatal regions in OCD subjects relative to matched 
comparison subjects (Piantadosi, et al. 2019, accepted, Molecular Psychiatry). This finding 
provides further support for the use of Sapap3-KO mice to probe the neural circuitry that has been 
implicated in OCD. 
In this thesis, I reported that striatal hyperactivity observed in Sapap3-KO mice was driven 
by increased recruitment of spiny projection neurons at the onset of grooming. After 7 days of 
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fluoxetine treatment, the compulsive grooming phenotype of Sapap3-KO mice was significantly 
reduced, and there was a significant decrease in the percent of grooming onset-activated SPNs. 
These findings could potentially indicate that the broad striatal hyperactivity measured via PET 
and fMRI in OCD patients is the result of more individual cells being active, rather than a stronger 
upstream drive onto striatal neurons. 
In addition to reducing the compulsive grooming behavior of Sapap3-KO mice with 
fluoxetine treatment, our lab has shown that 5 days of treatment with a 5-HT2C-specific receptor 
agonist also significantly reduces grooming in Sapap3-KO mice (Piantadosi & Ahmari, 
unpublished observations). Given that 5-HT2C receptors are selectively expressed on FSIs, these 
findings support our working hypothesis that increased activation of striatal FSIs can reduce 
behavioral compulsivity by reducing overall striatal gain and points toward 5-HT2C receptors as 
clinically relevant targets for future drug developments. 
Interestingly, the results of the present study indicate that overall striatal hyperactivity in 
Sapap3-KO mice is not driven by hyperactivity of D1 receptor-expressing SPNs. In fact, D1-SPNs 
were hypoactive at grooming onset in Sapap3-KO mice relative to WT littermates. While it is 
necessary to perform in vivo calcium imaging in A2A-cre Sapap3-KOs and WTs before making 
any strong assertions, as it currently stands, it appears that D1-SPNs play a smaller role in driving 
compulsive grooming in Sapap3-KO mice than expected. The findings in this translational model 
could potentially shift our current understanding of the neural mechanisms underlying compulsive 
symptoms of OCD patients and how we might optimize pharmacologic treatments to increase their 
effectiveness. Specifically, these data suggest that developing drugs that can specifically influence 
individual cell-types could yield greater clinical outcomes. As with any translational research, the 
impact of the results presented in this thesis must be viewed through a critical lens. However, the 
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present findings provide potentially relevant insights into the circuit level mechanisms underlying 
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